Serum galectin-3 levels in patients with nonalcoholic fatty liver disease

YILMAZ, YUSUF; EREN, FATİH; Kurt, Ramazan; Yonal, Oya; Polat, Zulfikar; Senates, Ebubekir; Bacha, Mohammad; Imeryuz, Nese

doi:10.1016/j.clinbiochem.2011.05.015

Serum galectin-3 levels in patients with nonalcoholic fatty liver disease

Atıf İçin Kopyala

YILMAZ Y., EREN F., Kurt R., Yonal O., Polat Z., Senates E., ...Daha Fazla

CLINICAL BIOCHEMISTRY, cilt.44, sa.12, ss.955-958, 2011 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 44 Sayı: 12
Basım Tarihi: 2011
Doi Numarası: 10.1016/j.clinbiochem.2011.05.015
Dergi Adı: CLINICAL BIOCHEMISTRY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.955-958
Anahtar Kelimeler: Galectin-3, Nonalcoholic fatty liver disease, Enzyme-linked immunosorbent assay, Biopsy, METABOLIC SYNDROME, STEATOHEPATITIS, ASSOCIATION, OBESITY, MICE
Marmara Üniversitesi Adresli: Evet

Özet

Objectives: Galectin-3 might serve as a biomarker of human metabolic alterations. We measured serum levels of galectin-3 in patients with nonalcoholic fatty liver disease (NAFLD) and examined their association with clinical and histological phenotypes.